Article Information
PubMed
Published By
History
- Received December 6, 2005
- Revision received July 19, 2006
- Accepted July 20, 2006
- First published August 23, 2006.
- Version of record published August 23, 2006.
Copyright & Usage
Copyright © 2006 Society for Neuroscience 0270-6474/06/268866-09$15.00/0
Author Information
- 1Departments of Anatomy and Biochemistry and Biophysics, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California 94143,
- 2Departments of Neurology and Neurosurgery and Anatomy and Cell Biology, Center for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4, and
- 3Division of Research, Genentech, South San Francisco, California 94080
- Correspondence should be addressed to Marc Tessier-Lavigne, Genentech Incorporated, 1 DNA Way, South San Francisco, CA 94080. marctl{at}gene.com
Author contributions
Disclosures
- Received December 6, 2005.
- Revision received July 19, 2006.
- Accepted July 20, 2006.
-
This work was supported by grants to M.T.-L. from the National Institutes of Health and the Howard Hughes Medical Institute and by grants to T.E.K. from the Canadian Institutes of Health Research, the Fonds de la Recherche en Santé du Québec, and Paralyzed Veterans of America Spinal Cord Research Foundation. We thank Konrad Beyreuther for suggesting the antigen enhancement protocol; Sasha Feynboym, Elena Malitskaya, and Erika Kennedy for technical assistance; and Christine Mirzayan and Lindsay Hinck for providing recombinant netrin protein.
- Correspondence should be addressed to Marc Tessier-Lavigne, Genentech Incorporated, 1 DNA Way, South San Francisco, CA 94080. marctl{at}gene.com
Online Impact